— Know what they know.
Not Investment Advice

MEDS NASDAQ

DataMEDS AI, Inc.
1W: +18.3% 1M: +257.3% 3M: -48.3% YTD: +26.5% 1Y: +18.7% 3Y: -82.7% 5Y: -94.8%
$3.68
-0.38 (-9.36%)
 
Weekly Expected Move ±146.1%
$-7 $-2 $4 $9 $14
NASDAQ · Healthcare · Medical - Distribution · Tech Score Buy · Power 54 · $9.7M mcap · 1M float · 403.54% daily turnover · Short 58% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$9.7M
52W Range0.8225-73
Volume1,148,990
Avg Volume4,241,202
Beta-1.52
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOPrashant Patel
Employees31
SectorHealthcare
IndustryMedical - Distribution
IPO Date2025-02-21
3000 Bayport Drive, Suite 950
Tampa, FL 33607
US
844 203 6092
About DataMEDS AI, Inc.

DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.

Recent Insider Trades

NameTypeSharesPriceDate
Shankar Hariharan 0 — 2024-07-25
Shankar Hariharan 0 — 2024-07-25
Shankar Hariharan 356,480 — 2024-07-25
Shankar Hariharan 1,916,816 — 2024-07-25
Narasimhan Mani 0 — 2024-07-25

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms